Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines

22 Apr 2016

Abstract excerpt

The World Health Organization has indicated that we are entering into a post-antibiotic era in which infections that were routinely and successfully treated with antibiotics can now be lethal due to the global dissemination of multidrug resistant strains. Conjugate vaccines are an effective way to create a long-lasting immune response against bacteria. However, these vaccines present many drawbacks such as slow...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Infections and Vaccines
Share to Bacteriophages and microbial interactions
Share to Pneumonia and Respiratory Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27103188
DOI: 10.1038/srep24931

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial VaccinesPMID 27103188Read ↗

Development of a Promising Bivalent Vaccine Against Klebsiella pneumoniae Based on Glycoengineered GMMA (geGMMA)Semantic proximity Read ↗

A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in miceSemantic proximity Read ↗

Development of a novel glycoengineering platform for the rapid production of conjugate vaccinesSemantic proximity Read ↗

Development of a novel glycoengineering platform for the rapid production of conjugate vaccinesSemantic proximity Read ↗

Outer Membrane Vesicle Vaccine PlatformsSemantic proximity Read ↗

Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal SalmonellaSemantic proximity Read ↗

Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccineSemantic proximity Read ↗

Naturally secreted bacterial outer membrane vesicles: potential platform for a vaccine against <i>Campylobacter jejuni</i>Semantic proximity Read ↗

Outer membrane vesicles as platform vaccine technologySemantic proximity Read ↗

GMMA-Based Vaccines: The Known and The UnknownSemantic proximity Read ↗

Potential of bacterial outer membrane vesicles in tumor vaccine: characteristics, advancements, and future directionsSemantic proximity Read ↗

Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.